Hip fracture device study pulled before it began
NCT ID NCT05559736
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to test a new metal implant called the Artemis Proximal Femoral Nail for fixing a common type of hip fracture. The plan was to compare results from patients who received this implant to similar patients from the past who received other implants. However, the study was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Artemis Proximal Femoral Nail (PFN) implant
What this could lead to
If successful, this could provide a safe and effective option for surgically fixing certain hip fractures.
What could go wrong
This trial was withdrawn before enrolling any participants, so no data is available. The device already has FDA clearance, but this pilot study was never conducted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMORAL FRACTURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21244, United States